The gain of copy number variations (CNV) for PCFT (SLC46A1), compared to the normal brain tissue, was detected in 25% of glioblastoma cases, with CNV loss in 68.75% (data obtained from 16 cases). The gene discussed is SLC46A1; the disease is glioblastoma.